戻る Agenda
Remote Implementation of Clinical Outcome Assessments During the COVID-19 Pandemic and Beyond
Session Chair(s)
Elektra Papadopoulos, MD, MPH
Director, Patient Experience Data and Strategy
AbbVie, United States
Remote clinical outcome assessments (COAs) enable conduct of decentralized trials and played a pivotal role in adapting trials during the COVID-19 pandemic. A multi-stakeholder panel will discuss considerations for implementing COAs remotely.
Learning Objective : Describe considerations for remote implementation of COAs during and after COVID-19; Discuss opportunities and challenges to implement remote COAs in clinical trials; Discuss key aspects of data collection and analysis when using remote COAs.
Speaker(s)
Industry Update
Isaac R Rodriguez-Chavez, MHS, PhD, MS
4Biosolutions Consulting, United States
EMA Update
Maria Tome, MD, PhD, FFPM
European Medicines Agency, Netherlands
Pharma Medicine Physician, Senior Scientific Advisor, Scientific Advice
Industry Update
Kai Langel
Janssen, Spain
Senior Director, Strategy and Innovation, Global Regulatory Policy